CIK: 0001281446 · Show all filings
Period: Q4 2017 (← Previous) (Next →)
Filing Date: Feb 14, 2018
Total Value ($000): $586,066 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ZOGENIX INC CMN | 1,121,331 | $44,909 | 7.7% | $14.10 | — | COM NEW | 98978L204 |
| — | ARENA PHARMACEUTICALS, INC. CMN | 1,177,119 | $39,987 | 6.8% | $16.87 | — | COM NEW | 040047607 |
| KURA | KURA ONCOLOGY, INC. CMN | 2,197,283 | $33,618 | 5.7% | $10.47 | +40.7% | COM | 50127T109 |
| — | SAGE THERAPEUTICS, INC CMN | 200,000 | $32,942 | 5.6% | $94.62 | — | COM | 78667J108 |
| — | GLOBAL BLOOD THERAPEUTICS, INC. CMN | 803,205 | $31,606 | 5.4% | $28.28 | — | COM | 37890U108 |
| NBIX | NEUROCRINE BIOSCIENCES INC CMN | 400,000 | $31,036 | 5.3% | $43.70 | +56.1% | COM | 64125C109 |
| — | RIGEL PHARMACEUTICALS INC CMN | 7,888,581 | $30,608 | 5.2% | $3.31 | — | COM NEW | 766559603 |
| — | FOAMIX PHARMACEUTICALS LIMITED CMN | 4,781,708 | $28,738 | 4.9% | $7.50 | — | SHS | M46135105 |
| BCRX | BIOCRYST PHARMACEUTICALS INC CMN | 4,751,883 | $23,332 | 4.0% | $4.94 | -1.9% | COM | 09058V103 |
| — | AIMMUNE THERAPEUTICS, INC. CMN | 573,550 | $21,692 | 3.7% | $23.50 | — | COM | 00900T107 |
| — | SPARK THERAPEUTICS INC CMN | 410,900 | $21,128 | 3.6% | $51.42 | — | COM | 84652J103 |
| PTCT | PTC THERAPEUTICS, INC. CMN | 1,085,800 | $18,111 | 3.1% | $12.42 | +36.3% | COM | 69366J200 |
| NVCR | NOVOCURE, LTD. CMN | 879,286 | $17,762 | 3.0% | $19.34 | -0.4% | ORD SHS | G6674U108 |
| — | CONCERT PHARMACEUTICALS INC CMN | 669,472 | $17,319 | 3.0% | $17.06 | — | COM | 206022105 |
| — | NEWLINK GENETICS CORPORATION CMN | 1,987,099 | $16,115 | 2.7% | $8.11 | — | COM | 651511107 |
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. CMN | 2,000,000 | $16,000 | 2.7% | $6.33 | +26.8% | COM | 462260100 |
| — | AXOVANT SCIENCES LTD CMN | 2,850,000 | $15,020 | 2.6% | $5.28 | — | COM | G0750W104 |
| CPRX | CATALYST PHARMACEUTICAL INC.CMN | 3,817,288 | $14,926 | 2.5% | $3.30 | 0.0% | COM | 14888U101 |
| — | BIOHAVEN PHARMACEUTICAL HOLDING CO LTD. CMN | 500,192 | $13,495 | 2.3% | $26.98 | — | COM | G11196105 |
| SVRA | SAVARA INC CMN | 869,500 | $12,903 | 2.2% | $11.47 | 0.0% | COM | 805111101 |
| VNDA | VANDA PHARMACEUTICALS INC. CMN | 797,531 | $12,122 | 2.1% | $12.36 | +20.0% | COM | 921659108 |
| WVE | WAVE LIFE SCIENCES PTE LTD CMN | 331,085 | $11,621 | 2.0% | $29.15 | 0.0% | SHS | Y95308105 |
| — | REVANCE THERAPEUTICS INC CMN | 300,000 | $10,725 | 1.8% | $35.75 | — | COM | 761330109 |
| — | GW PHARMACEUTICALS PLC ADR CMN | 75,000 | $9,901 | 1.7% | $132.01 | — | ADS | 36197T103 |
| — | GLOBAL BLOOD THERAPEUTICS, INC. CMN | 200,000 | $7,870 | 1.3% | $28.28 | — | Call | 37890U108 |
| — | DBV TECHNOLOGIES SA SPONSORED ADR CMN | 313,140 | $7,703 | 1.3% | $35.48 | — | SPONSORED ADR | 23306J101 |
| — | ACCELERON PHARMA INC CMN | 173,124 | $7,347 | 1.3% | $28.27 | — | COM | 00434H108 |
| INCY | INCYTE CORPORATION CMN | 70,323 | $6,660 | 1.1% | $104.52 | 0.0% | COM | 45337C102 |
| — | CIDARA THERAPEUTICS, INC. | 800,000 | $5,440 | 0.9% | $6.80 | — | COM | 171757107 |
| — | ACORDA THERAPEUTICS INC CMN | 200,000 | $4,290 | 0.7% | — | — | Put | 00484M106 |
| — | CORBUS PHARMACEUTICALS HOLDINGS, INC. CMN | 600,000 | $4,260 | 0.7% | $7.10 | — | COM | 21833P103 |
| — | AMARIN CORPORATION PLC SPONSORED ADR CMN | 1,056,825 | $4,238 | 0.7% | $4.03 | — | SPONS ADR NEW | 023111206 |
| — | JOUNCE THERAPEUTICS INC CMN | 292,673 | $3,732 | 0.6% | $12.75 | — | COM | 481116101 |
| — | KADMON HOLDINGS INC CMN | 840,303 | $3,042 | 0.5% | $3.62 | — | COM | 48283N106 |
| — | MYOVANT SCIENCES LTD CMN | 160,530 | $2,029 | 0.3% | $12.34 | — | COM | G637AM102 |
| — | SELECTA BIOSCIENCES, INC. | 177,900 | $1,745 | 0.3% | $19.86 | — | COM | 816212104 |
| — | DERMIRA INC CMN | 43,637 | $1,214 | 0.2% | $27.82 | — | COM | 24983L104 |
| — | CONNECTURE INC | 4,127,232 | $660 | 0.1% | $9.01 | — | COM | 20786J106 |
| — | STREAMLINE HEALTH SOLUTNS, INC CMN | 130,137 | $220 | 0.0% | $6.45 | — | COM | 86323X106 |